63
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Subcutaneous gentamicin injection around the cuff in treatment of resistant exit site infection in peritoneal dialysis patients: a pilot study

, , &
Pages 909-914 | Published online: 20 Jul 2017

References

  • MontenegroJPrevention and treatment of peritoneal catheter exit-site infectionNefrología199919502507
  • KolesnykIDekkerFWBoeschotenEWKredietRTTime dependent reasons for peritoneal dialysis technique failure and mortalityPerit Dial Int201030217017720124193
  • TroidleLGorban–BrennanNKligerAFinkelsteinFDiffering outcomes of gram-positive and gram-negative peritonitisAm J Kidney Dis19983246236289774124
  • WardACampoli–RichardsDMMupirocin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic useDrugs1986324254443098541
  • ZimmermanSWO’BrienMWiedenhoeftFJohnsonCStaphylococcus aureus peritoneal catheter-related infections: a cause of catheter loss and peritonitisPerit Dial Int19888191194
  • EykynSJStaphylococcal sepsis. The changing pattern of disease and therapyLancet1988185771001032891941
  • CafferkeyMTTherapy for staphylococcal infectionCurr Opin Infect Dis19914757764
  • No authors listedRevised guidelines for the control of epidemic methicillin-resistant Staphylococcus aureusJ Hosp Infect19901643513771980508
  • TurnerKUttleyLScrimgeourAMckewanAGokalRNatural history of Staphylococcal aureus nasal carriage and its relationship to exit site infectionPerit Dial Int19981832712739663890
  • WongSSChuKHCheukAProphylaxis against gram-positive organisms causing exit-site infection and peritonitis in continuous ambulatory peritoneal dialysis patients by applying mupirocin ointment at the catheter exit sitePerit Dial Int200323Suppl 2153158
  • BernardiniJPirainoBHolleyJJohnstonJRLutesRA randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampicinAm J Kidney Dis1996276957008629630
  • LimCTWongKSFooMWThe impact of topical mupirocin on peritoneal dialysis infection rates in Singapore General HospitalNephrol Dial Transplant20052081702170615855200
  • UttleyLVardhanAMahajanSSmartBHutchisonAGokalRDecrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit siteJ Nephrol200417224224515293524
  • MahajanSTiwariSCKalraVEffect of local mupirocin application on exit site infection and peritonitis in an Indian peritoneal dialysis populationPerit Dial Int200525547347716178481
  • LiPKSzetoCCPirainoBPeritoneal dialysis-related infections recommendations: 2010 updatePerit Dial Int201030439342320628102
  • SchaeferFKlausGMuller-WiefelDEMehlsOIntermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS)J Am Soc Nephrol19991011361459890319
  • FentonSSSchaubelDEDesmeulesMHemodialysis versus peritoneal dialysis: a comparison of adjusted mortality ratesAm J Kidney Dis19973033343429292560
  • FriedLAbidiSBernardiniJJohnstonJRPirainoBHospitalization in peritoneal dialysis patientsAm J Kidney Dis199933592793310213651
  • GolperTABrierMEBunkeMRisk factors for peritonitis in long-term peritoneal dialysis: the Network 9 peritonitis and catheter survival studiesAm J Kidney Dis19962834284368804243
  • FriedLFBernardiniJJohnstonJRPirainoBPeritonitis influences mortality in peritoneal dialysis patientsJ Am Soc Nephrol1996710217621828915978
  • AbrahamGSavinEBlakePDombrosNSímbolosKNatural history of exit-site infection in patients on CAPDPerit Dial Bull19883211216
  • LoCYChuWLWanKMPseudomonas exit-site infections in CAPD patients: evolution and outcome of treatmentPerit Dial Int19981866376409932663
  • SzaboTSiccionZIzattSVasSIBargmanJOreopoulosDGOutcome of Pseudomonas aeruginosa exit-site and tunnel infections: a single center’s experienceAdv Perit Dial19991520921210682104
  • BurkhalterFClemengerMHaddoubSSMcGroryJHisoleNBrownEPseudomonas exit-site infection: treatment outcomes with topical gentamicin in addition to systemic antibioticsClin Kidney J20158678178426613039
  • KazmiHRRaffoneFDKligerASFinkelsteinFOPseudomonas exit site infections in continuous ambulatory peritoneal dialysis patientsJ Am Soc Nephrol19922149815011600121
  • MontenegroJSarachoRAguirreRMartinezIIribarIOcharanJExit-site care with ciprofloxacin otologic solution prevents polyurethane catheter infection in peritoneal dialysis patientsPerit Dial Int200020220921410809245
  • BernardiniJBenderFFlorioTRandomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patientsJ Am Soc Nephrol200516253954515625071